GT Biopharma (GTBP) & The Race To Commercialize Breakthrough Immunotherapies

The recent events surrounding natural killer (NK) cell therapy have begun to…

How One Pot Stock Could Be Positioning For Canada’s Green Rush

In a little over two 60 days, the date Canadian cannabis investors…

The Science Of A Trade

We’ve all come here for one reason: Getting Information on Stocks. With…